Glucocorticoid_NN
receptors_NNS
on_IN
mononuclear_JJ
leukocytes_NNS
in_IN
polycystic_JJ
ovary_NN
syndrome_NN
._.

OBJECTIVE_NN
:_:
Many_JJ
studies_NNS
have_VBP
suggested_VBN
that_IN
there_EX
is_VBZ
a_DT
possible_JJ
hormonal_JJ
dysregulation_NN
of_IN
hypothalamic-pituitary-adrenal_JJ
-LRB-_-LRB-
HPA_NN
-RRB-_-RRB-
axis_NN
and_CC
an_DT
increased_VBN
cortisol_NN
clearance_NN
in_IN
patients_NNS
with_IN
polycystic_JJ
ovary_NN
syndrome_NN
-LRB-_-LRB-
PCOS_NN
-RRB-_-RRB-
._.

Therefore_RB
in_IN
this_DT
study_NN
,_,
we_PRP
have_VBP
examined_VBN
the_DT
role_NN
of_IN
glucocorticoid_NN
receptor\/s_NN
-LRB-_-LRB-
GR_NN
-RRB-_-RRB-
characteristics_NNS
in_IN
the_DT
developing_NN
of_IN
these_DT
abnormalities_NNS
in_IN
patients_NNS
with_IN
PCOS_NN
._.

METHOD_NN
:_:
For_IN
this_DT
purpose_NN
,_,
the_DT
number_NN
and_CC
affinity_NN
of_IN
GR_NN
in_IN
peripheral_JJ
mononuclear_JJ
leukocytes_NNS
-LRB-_-LRB-
MNL_NN
-RRB-_-RRB-
of_IN
10_CD
patients_NNS
with_IN
PCOS_NN
and_CC
10_CD
healthy_JJ
women_NNS
-LRB-_-LRB-
controls_NNS
-RRB-_-RRB-
were_VBD
determined_VBN
._.

RESULTS_NNS
:_:
There_EX
were_VBD
no_DT
significant_JJ
differences_NNS
in_IN
the_DT
number_NN
-LRB-_-LRB-
6500_CD
+_NN
\/_:
-1001_CD
sites\/cell_NNS
and_CC
6352_CD
+_CC
\/_CD
-1697_CD
sites\/cell_NNS
,_,
respectively_RB
;_:
P_NN
&gt;_JJR
0.05_CD
-RRB-_-RRB-
and_CC
affinity_NN
-LRB-_-LRB-
3.93_CD
+_CC
\/_RB
-0.89_CD
nM_NN
and_CC
4.49_CD
+_CC
\/_RB
-0.71_CD
nM_NN
,_,
respectively_RB
;_:
P_NN
&gt;_JJR
0.05_CD
-RRB-_-RRB-
of_IN
GR_NN
between_IN
the_DT
PCOS_NN
patients_NNS
and_CC
the_DT
controls_NNS
._.

CONCLUSIONS_NNS
:_:
These_DT
results_NNS
suggest_VBP
that_IN
the_DT
alterations_NNS
in_IN
the_DT
HPA_JJ
axis_NN
and_CC
in_IN
the_DT
cortisol_NN
metabolism_NN
observed_VBN
in_IN
PCOS_NN
are_VBP
not_RB
related_JJ
to_TO
GR_NN
deficiency_NN
._.

